Evidence map›Paper›PMID 31792571›Full record

ArticleClinical research in cardiology : official journal of the German Cardiac Society2020

One-year clinical outcomes in patients with renal insufficiency after contemporary PCI: data from a multicenter registry.

Sean S Scholz, Lucas Lauder, Sebastian Ewen, Saarraaken Kulenthiran, Nikolaus Marx, Orazbek Sakhov, Floris Kauer, Adam Witkowski, Marco Vaglimigli, William Wijns and 3 more

Erratum issuedAbstract readMulticenter Study
In one paragraph

Article in Clinical research in cardiology : official journal of the German Cardiac Society, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Intravascular Brachytherapy for In-Stent Restenosis in Patients With Chronic Kidney Disease.Journal of the Society for Cardiovascular Angiography & Interventions · 2025
    Article
  6. Clinical outcomes after complex and high-risk percutaneous coronary intervention according to baseline chronic kidney disease.Clinical research in cardiology : official journal of the German Cardiac Society · 2025
    Article
  7. Article
  8. Observational
  9. Review
  10. Article
  11. Article
  12. Article
  13. Observational
  14. Dual-axis rotational coronary angiography versus conventional coronary angiography: a randomized comparison.Clinical research in cardiology : official journal of the German Cardiac Society · 2021
    Article
  15. Review
  16. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Sean S ScholzKlinik für Innere Medizin III, Kardiologie, Angiologie Und Internistische Intensivmedizin, Saarland University Hospital, Saarland University, Kirrberger Str. 1, Geb. 41, IMED, 66421, Homburg/Saar, Germany. sean.scholz@uks.eu.ORCID http://orcid.org/0000-0002-6567-2022
Lucas LauderKlinik für Innere Medizin III, Kardiologie, Angiologie Und Internistische Intensivmedizin, Saarland University Hospital, Saarland University, Kirrberger Str. 1, Geb. 41, IMED, 66421, Homburg/Saar, Germany.
Sebastian EwenKlinik für Innere Medizin III, Kardiologie, Angiologie Und Internistische Intensivmedizin, Saarland University Hospital, Saarland University, Kirrberger Str. 1, Geb. 41, IMED, 66421, Homburg/Saar, Germany.
Saarraaken KulenthiranKlinik für Innere Medizin III, Kardiologie, Angiologie Und Internistische Intensivmedizin, Saarland University Hospital, Saarland University, Kirrberger Str. 1, Geb. 41, IMED, 66421, Homburg/Saar, Germany.
Nikolaus MarxMedizinische Klinik I, Klinik für Kardiologie, Angiologie Und Internistische Intensivmedizin, RWTH Aachen University, Aachen, Germany.
Orazbek SakhovDepartment of Interventional Cardiology, City Heart Center, Almaty, Kazakhstan.
Floris KauerDepartment of Cardiology, Albert Schweitzer Ziekenhius, Dordrecht, Netherlands.
Adam WitkowskiDepartment of Interventional Cardiology and Angiology, Institute of Cardiology, Warsaw, Poland.
Marco VaglimigliUniversitätsklinik für Kardiologie, Universitätsspital Bern, Bern, Schweiz.
William WijnsThe Lambe Institute for Translational Medicine, National University of Ireland and Saolta University Healthcare Group, Galway, Ireland.
Bruno SchellerKlinik für Innere Medizin III, Kardiologie, Angiologie Und Internistische Intensivmedizin, Saarland University Hospital, Saarland University, Kirrberger Str. 1, Geb. 41, IMED, 66421, Homburg/Saar, Germany.
Michael BöhmKlinik für Innere Medizin III, Kardiologie, Angiologie Und Internistische Intensivmedizin, Saarland University Hospital, Saarland University, Kirrberger Str. 1, Geb. 41, IMED, 66421, Homburg/Saar, Germany.
Felix MahfoudKlinik für Innere Medizin III, Kardiologie, Angiologie Und Internistische Intensivmedizin, Saarland University Hospital, Saarland University, Kirrberger Str. 1, Geb. 41, IMED, 66421, Homburg/Saar, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChronic kidney disease (CKD) is highly prevalent in patients with coronary artery disease (CAD).

objectiveThe outcome following revascularization using contemporary technologies (new-generation abluminal sirolimus-eluting stents with thin struts) in patients with CKD (i.e., glomerular filtration rate of < 60 mL/min/1.73m

methodse-Ultimaster is a prospective, single-arm, multi-center registry with clinical follow-up at 3 months and 1 year.

resultsA total of 19,475 patients were enrolled, including 1466 patients with CKD, with 167 undergoing HD. Patients with CKD had a higher prevalence of overall comorbidities, multiple/small vessel disease (≤ 2.75 mm), bifurcation lesions, and more often left main artery treatments (all p < 0.0001) when compared with patients with normal renal function (reference). CKD patients had a higher risk of target lesion failure (unadjusted OR, 2.51 [95% CI 2.04-3.08]), target vessel failure (OR, 2.44 [95% CI 2.01-2.96]), patient-oriented composite end point (OR, 2.19 [95% CI 1.87-2.56]), and major adverse cardiovascular events (OR, 2.34 [95% CI 1.93-2.83, p for all < 0.0001]) as reference. The rates of target lesion revascularization (OR, 1.17 [95% CI 0.79-1.73], p = 0.44) were not different. Bleeding complications were more frequently observed in CKD than in the reference (all p < 0.0001).

conclusionIn this worldwide registry, CKD patients presented with more comorbidities and more complex lesions when compared with the reference population. They experienced higher rate of adverse events at 1-year follow-up. One-year summary outcomes of contemporary PCI in renal insufficiency. CKD chronic kidney disease, POCE patient oriented composite endpoint, MACE major adverse cardiovascular events, TLF target lesion failure, TLR target lesion revascularization, ST stent thrombosis.

Indexed as

Percutaneous Coronary InterventionAgedCohort StudiesCoronary Artery DiseaseDrug-Eluting StentsFemaleGlomerular Filtration RateHumansMaleMiddle AgedRegistriesRenal DialysisRenal Insufficiency, ChronicTime FactorsTreatment OutcomeChronic kidney diseaseDrug-eluting stentEnd-stage renal diseaseHemodialysisRegistry

Identifiers

PMID31792571
PMCPMC7308257

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.